Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.
Respiratory Virus Detection and Sequencing from SARS-CoV-2–Negative Rapid Antigen Tests
Emmanuela Jules
1, Charlie Decker
1, Brianna Jeanne Bixler
1, Alaa Ahmed, Zijing (Carol) Zhou, Itika Arora, Henok Tafesse, Hannah Dakanay, Andrei Bombin, Ethan Wang, Jessica Ingersoll, Kathy Bifulco, Jennifer K. Frediani, Richard Parsons, Julie Sullivan, Morgan Greenleaf, Jesse J. Waggoner, Greg S. Martin, Wilbur A. Lam, and Anne Piantadosi
Author affiliation: Emory University School of Medicine, Atlanta, Georgia, USA (E. Jules, C. Decker, B.J. Bixler, A. Ahmed, Z.(C.) Zhou, I. Arora, H. Tafesse, H. Dakanay, A. Bombin, E. Wang, J. Ingersoll, J. Sullivan, J.J. Waggoner, W.A. Lam, A. Piantadosi); Emory Integrated Genomics Core, Winship Cancer Institute of Emory University, Atlanta (A. Ahmed); Nell Hodgson Woodruff School of Nursing, Emory University, Atlanta (K. Bifulco, J.K. Frediani, R. Parsons); The Atlanta Center for Microsystems Engineered Point-of-Care Technologies, Atlanta (J.K. Frediani, R. Parsons, J. Sullivan, M. Greenleaf); Georgia Clinical and Translational Science Alliance, Atlanta (M. Greenleaf); Emory University Division of Pulmonary, Allergy, Critical Care Medicine and Sleep Medicine, Atlanta (G.S. Martin); Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta (W.A. Lam); Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta, Atlanta (W.A. Lam)
Main Article
Figure 1

Figure 1. Frequency of human pathogenic respiratory viruses found in 53 residual samples from SARS-CoV-2–negative BinaxNOW tests (Abbott, https://www.abbott.com) in study of respiratory virus detection and sequencing from negative rapid antigen tests. Pie charts indicate the number of samples positive for each virus among all samples (A) and among the 18 positive samples (B). Numbers indicate the number of samples with a virus identified, followed in parentheses by the number of samples with a >90% complete genome sequence assembled.
Main Article
Page created: March 31, 2025
Page updated: April 23, 2025
Page reviewed: April 23, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.